Free provider profile
MOHAMMAD QURESHI, M.D.
HAINES CITY, FL
Find similar providers: Psychiatrists in HAINES CITY, FL
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
863-547-0788
Fax
863-547-0789
Practice address
212 S DIXIE DR, HAINES CITY, FL, 33844
- Registry updated
- 2024-01-19
- NPI issued
- 2013-06-12
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Psychiatry & Neurology, Pain Medicine
2084P2900X
PrimaryPsychiatry & Neurology, Neurology
2084N0400X
2 registered practice locations · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like MOHAMMAD QURESHI?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What MOHAMMAD QURESHI prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Oxycodone-Acetaminophen
- Ubrelvy
- Qulipta
- Ztlido
- Aimovig Autoinjector
See all interventional pain specialists in FL who bill Medicare →
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
8,939
Medicare patients
658
Part D drug cost
$681,803
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ingrezza (Valbenazine Tosylate) | 15 | $113,799 |
| Ubrelvy (Ubrogepant) | 64 | $110,957 |
| Qulipta (Atogepant) | 40 | $59,338 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | 1,161 | $42,454 |
| Botox (Onabotulinumtoxina) | 25 | $30,502 |
| Aimovig Autoinjector (Erenumab-Aooe) | 27 | $28,982 |
| Nurtec Odt (Rimegepant Sulfate) | 13 | $25,724 |
| Ztlido (Lidocaine) | 39 | $20,221 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across FL — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
